Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract 2207: High-dose omega-3 fatty acid supplementation is associated with a decrease in FOXA1 in benign breast tissue

Carol J. Fabian, Trina Metheny, Teresa A. Phillips, Marsha Danley, Bruce F. Kimler

Cancer Res (2022) 82 (12_Supplement): 2207.

https://doi.org/10.1158/1538-7445.AM2022-2207

Published: 15 June 2022

View article titled, Abstract 2207: High-dose omega-3 fatty acid supplementation is associated with a decrease in FOXA1 in benign breast tissue

Journal Articles

Abstract P1-10-04: AGR2, an estrogen response gene associated with tamoxifen resistance, is modulated by acolbifene in premenopausal women at high risk for development of breast cancer

Carol J. Fabian, Teresa A. Phillips, Bruce F. Kimler

Cancer Res (2022) 82 (4_Supplement): P1-10-04.

https://doi.org/10.1158/1538-7445.SABCS21-P1-10-04

Published: 15 February 2022

View article titled, Abstract P1-10-04: AGR2, an estrogen response gene associated with tamoxifen resistance, is modulated by acolbifene in premenopausal women at high risk for development of breast cancer

Journal Articles

Abstract P2-11-17: Feasibility of microbiome analysis from random periareolar fine needle aspiration in premenopausal women at increased risk for breast cancer

Lauren E Nye, Jennifer R Klemp, Kandy R Powers, Anne P O'Dea, Amy L Kreutzjans, Trina Metheny, Teresa A Phillips, Susan E Carlson, Bruce F Kimler, Carol J Fabian

Cancer Res (2022) 82 (4_Supplement): P2-11-17.

https://doi.org/10.1158/1538-7445.SABCS21-P2-11-17

Published: 15 February 2022

View article titled, Abstract P2-11-17: Feasibility of microbiome analysis from random periareolar fine needle aspiration in premenopausal women at increased risk for breast cancer

Journal Articles

Abstract PD11-02: Randomized trial of 12 months of omega-3 fatty acids vs placebo during a weight loss intervention in post-menopausal women at increased risk for breast cancer

Carol J Fabian, Christie A Befort, Debra K Sullivan, Susan E Carlson, Jennifer L Nydegger, Amy L Kreutzjans, Kandy R Powers, Teresa A. Phillips, Trina Metheny, Carola M Zalles, Erin D Giles, Stephen D Hursting, Bruce F Kimler

Cancer Res (2021) 81 (4_Supplement): PD11-02.

https://doi.org/10.1158/1538-7445.SABCS20-PD11-02

Published: 15 February 2021

View article titled, Abstract PD11-02: Randomized trial of 12 months of omega-3 fatty acids vs placebo during a weight loss intervention in post-menopausal women at increased risk for breast cancer

Journal Articles

Abstract 1120: Randomized clinical trial of a flaxseed lignan in pre-menopausal women at high risk for development of breast cancer

Carol J. Fabian, Seema A. Khan, Judy E. Garber, William C. Dooley, Lisa D. Yee, Carola M. Zalles, Trina Metheny, Teresa A. Phillips, Jinxiang Hu, Brian K. Petroff, Stephen D. Hursting, Bruce F. Kimler

Cancer Res (2020) 80 (16_Supplement): 1120.

https://doi.org/10.1158/1538-7445.AM2020-1120

Published: 15 August 2020

View article titled, Abstract 1120: Randomized clinical trial of a flaxseed lignan in pre-menopausal women at high risk for development of breast cancer

Journal Articles

Abstract P1-14-01: Feasibility study of moderate dose omega 3 fatty acid supplementation in premenopausal women at high risk for breast cancer considering future pregnancy

Lauren E Nye, Jennifer R Klemp, Kandy R Powers, Anne P O'Dea, Kendra A Cruz, Amy L Kreutzjans, Trina Metheny, Teresa A Phillips, Susan E Carlson, Bruce F Kimler, Carol J Fabian

Cancer Res (2020) 80 (4_Supplement): P1-14-01.

https://doi.org/10.1158/1538-7445.SABCS19-P1-14-01

Published: 15 February 2020

View article titled, Abstract P1-14-01: Feasibility study of moderate dose omega 3 fatty acid supplementation in premenopausal women at high risk for breast cancer considering future pregnancy

Journal Articles

Abstract PD3-06: Biomarker modulation by bazedoxifene and conjugated estrogen (Duavee®) in women at high risk for development of breast cancer

Carol J Fabian, Lauren Nye, Teresa A Phillips, Onalisa Winblad, Carola M Zalles, Christy R Hagan, Merit L Goodman, Byron J Gajewski, Devin C Koestler, Prabhakar Chalise, Bruce F Kimler

Cancer Res (2020) 80 (4_Supplement): PD3-06.

https://doi.org/10.1158/1538-7445.SABCS19-PD3-06

Published: 15 February 2020

View article titled, Abstract PD3-06: Biomarker modulation by bazedoxifene and conjugated estrogen (Duavee®) in women at high risk for development of breast cancer

Journal Articles

Abstract 2425: Moderate to vigorous physical activity reduces visceral adipose tissue in obese breast cancer survivors undergoing a weight loss intervention

Carol J. Fabian, Jennifer R. Klemp, Jeffrey M. Burns, Eric D. Vidoni, Lauren Nye, Christie A. Befort, Jill M. Hamilton-Reeves, Debra K. Sullivan, Teresa A. Phillips, Stephen D. Hursting, Bruce F. Kimler

Cancer Res (2019) 79 (13_Supplement): 2425.

https://doi.org/10.1158/1538-7445.AM2019-2425

Published: 01 July 2019

View article titled, Abstract 2425: Moderate to vigorous physical activity reduces visceral adipose tissue in obese breast cancer survivors undergoing a weight loss intervention

Journal Articles

Abstract 3261: Pilot study of the combination of bazedoxifene and conjugated estrogen to modulate risk biomarkers in women with hot flashes at increased risk for breast cancer

Carol J. Fabian, Kandy R. Powers, Jennifer L. Nydegger, Amy L. Kreutzjans, Trina Metheny, Teresa A. Phillips, Lauren Nye, Carola M. Zalles, Bruce F. Kimler

Cancer Res (2018) 78 (13_Supplement): 3261.

https://doi.org/10.1158/1538-7445.AM2018-3261

Published: 01 July 2018

View article titled, Abstract 3261: Pilot study of the combination of bazedoxifene and conjugated estrogen to modulate risk biomarkers in women with hot flashes at increased risk for breast cancer

Journal Articles

Abstract 1789: Estrogen receptor alpha and beta gene expression in benign breast tissue of high risk premenopausal women treated with the SERM acolbifene

Bruce F. Kimler, Teresa A. Phillips, Carol J. Fabian

Cancer Res (2016) 76 (14_Supplement): 1789.

https://doi.org/10.1158/1538-7445.AM2016-1789

Published: 15 July 2016

View article titled, Abstract 1789: Estrogen receptor alpha and beta gene expression in benign breast tissue of high risk premenopausal women treated with the SERM acolbifene

Journal Articles

Abstract 158: Modulation of breast tissue biomarkers by high dose omega-3 fatty acid supplementation in women at high risk for development of breast cancer.

Carol J. Fabian, Bruce F. Kimler, Carola M. Zalles, Trina Metheny, Jessica A. Box, Jennifer L. Nydegger, Teresa A. Phillips, Brandon H. Hidaka, Susan E. Carlson

Cancer Res (2013) 73 (8_Supplement): 158.

https://doi.org/10.1158/1538-7445.AM2013-158

Published: 15 April 2013

View article titled, Abstract 158: Modulation of breast tissue biomarkers by high dose omega-3 fatty acid supplementation in women at high risk for development of breast cancer.

Journal Articles

Abstract 2053: Regulation of microRNA-10b by CCN5/WISP-2 in breast cancer: A novel mechanism of CCN5/WISP-2 mediated suppression of invasive front

Inamul Haque, Snigdha Banerjee, Smita Mehta, Teresa A. Phillips, Gopal Dhar, Suman Kambhampati, Sushanta K. Banerjee

Cancer Res (2010) 70 (8_Supplement): 2053.

https://doi.org/10.1158/1538-7445.AM10-2053

Published: 15 April 2010

View article titled, Abstract 2053: Regulation of microRNA-10b by CCN5/WISP-2 in breast cancer: A novel mechanism of CCN5/WISP-2 mediated suppression of invasive front

Journal Articles

CCN5/WISP-2 Expression in Breast Adenocarcinoma Is Associated with Less Frequent Progression of the Disease and Suppresses the Invasive Phenotypes of Tumor Cells

Snigdha Banerjee, Gopal Dhar, Inamul Haque, Suman Kambhampati, Smita Mehta, Krishanu Sengupta, Ossama Tawfik, Teresa A. Phillips, Sushanta K. Banerjee

Cancer Res (2008) 68 (18): 7606–7612.

https://doi.org/10.1158/0008-5472.CAN-08-1461

Published: 14 September 2008

View article titled, CCN5/WISP-2 Expression in Breast Adenocarcinoma Is Associated with Less Frequent Progression of the Disease and Suppresses the Invasive Phenotypes of Tumor Cells

NARROW

Abstract 2207: High-dose omega-3 fatty acid supplementation is associated with a decrease in FOXA1 in benign breast tissue

Abstract P1-10-04: AGR2, an estrogen response gene associated with tamoxifen resistance, is modulated by acolbifene in premenopausal women at high risk for development of breast cancer

Abstract P2-11-17: Feasibility of microbiome analysis from random periareolar fine needle aspiration in premenopausal women at increased risk for breast cancer

Abstract PD11-02: Randomized trial of 12 months of omega-3 fatty acids vs placebo during a weight loss intervention in post-menopausal women at increased risk for breast cancer

Abstract 1120: Randomized clinical trial of a flaxseed lignan in pre-menopausal women at high risk for development of breast cancer

Abstract P1-14-01: Feasibility study of moderate dose omega 3 fatty acid supplementation in premenopausal women at high risk for breast cancer considering future pregnancy

Abstract PD3-06: Biomarker modulation by bazedoxifene and conjugated estrogen (Duavee®) in women at high risk for development of breast cancer

Abstract 2425: Moderate to vigorous physical activity reduces visceral adipose tissue in obese breast cancer survivors undergoing a weight loss intervention

Abstract 3261: Pilot study of the combination of bazedoxifene and conjugated estrogen to modulate risk biomarkers in women with hot flashes at increased risk for breast cancer

Abstract 1789: Estrogen receptor alpha and beta gene expression in benign breast tissue of high risk premenopausal women treated with the SERM acolbifene

Abstract 158: Modulation of breast tissue biomarkers by high dose omega-3 fatty acid supplementation in women at high risk for development of breast cancer.

Abstract 2053: Regulation of microRNA-10b by CCN5/WISP-2 in breast cancer: A novel mechanism of CCN5/WISP-2 mediated suppression of invasive front

CCN5/WISP-2 Expression in Breast Adenocarcinoma Is Associated with Less Frequent Progression of the Disease and Suppresses the Invasive Phenotypes of Tumor Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only